Adma Biologics, Inc. SEC filings ADMA
Adma Biologics, Inc. has 999 filings in SEC EDGAR's recent list, going back to Jul 10, 2006. Its latest annual report, Form ARS, was filed on Apr 15, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 4, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 4, 2026 (results of operations). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 4 | Insider transaction | Nov 5, 2026 | Nov 5, 2026 |
| 144 | Notice of proposed sale | Nov 5, 2026 | — |
| 10-Q | Quarterly report | Nov 4, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 4, 2026 | Nov 4, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 7, 2026 | — |
| 10-Q | Quarterly report | Aug 5, 2026 | Jun 30, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 5, 2026 | Aug 5, 2026 |
| 4 | Insider transaction | Jul 28, 2026 | Jul 24, 2026 |
| 4 | Insider transaction | Jul 17, 2026 | Jul 16, 2026 |
| 8-K |
Current report
Shareholder vote results
|
Jun 2, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | May 28, 2026 | May 27, 2026 |
| 4 | Insider transaction | May 14, 2026 | May 12, 2026 |
| 4 | Insider transaction | May 12, 2026 | May 11, 2026 |
| 10-Q | Quarterly report | May 6, 2026 | Mar 31, 2026 |
| 8-K |
Current report
Results of operations
|
May 6, 2026 | May 6, 2026 |
| 8-K |
Current report
Other events
|
May 4, 2026 | May 4, 2026 |
| SCHEDULE 13G | Ownership over 5% (passive) | Apr 29, 2026 | — |
| ARS | Annual report to shareholders | Apr 15, 2026 | Dec 31, 2025 |
| DEFA14A | Additional proxy material | Apr 15, 2026 | — |
| DEF 14A | Proxy statement | Apr 15, 2026 | Jun 2, 2026 |
| 4 | Insider transaction | Apr 3, 2026 | Apr 1, 2026 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 27, 2026 | Mar 27, 2026 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Mar 26, 2026 | — |
| 4 | Insider transaction | Mar 17, 2026 | Mar 13, 2026 |
| 4 | Insider transaction | Mar 17, 2026 | Mar 16, 2026 |
| 144 | Notice of proposed sale | Mar 10, 2026 | — |
| 4 | Insider transaction | Mar 10, 2026 | Mar 6, 2026 |
| 4 | Insider transaction | Mar 10, 2026 | Mar 6, 2026 |
| 144 | Notice of proposed sale | Mar 9, 2026 | — |
| 4 | Insider transaction | Mar 9, 2026 | Mar 5, 2026 |
| 4 | Insider transaction | Mar 2, 2026 | Feb 26, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 2, 2026 | Mar 2, 2026 |
| 3 | Initial insider ownership | Feb 26, 2026 | Feb 26, 2026 |
| 10-K | Annual report | Feb 25, 2026 | Dec 31, 2025 |
| 8-K |
Current report
Results of operations, Officer or director change
|
Feb 25, 2026 | Feb 20, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 23, 2026 | Feb 19, 2026 |
| 4 | Insider transaction | Feb 17, 2026 | Feb 17, 2026 |
| 144 | Notice of proposed sale | Feb 17, 2026 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 12, 2026 | — |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 4 | Insider transaction | Feb 11, 2026 | Feb 9, 2026 |
| 8-K |
Current report
Results of operations, Regulation FD disclosure
|
Jan 12, 2026 | Jan 12, 2026 |
| 4 | Insider transaction | Dec 16, 2025 | Dec 15, 2025 |
| 4 | Insider transaction | Nov 21, 2025 | Nov 19, 2025 |
| 10-Q | Quarterly report | Nov 5, 2025 | Sep 30, 2025 |
| 8-K |
Current report
Results of operations
|
Nov 5, 2025 | Nov 5, 2025 |
| 4 | Insider transaction | Oct 24, 2025 | Oct 24, 2025 |
| 144 | Notice of proposed sale | Oct 24, 2025 | — |
| UPLOAD | Letter from the SEC | Sep 29, 2025 | — |
| CORRESP | Letter to the SEC | Sep 26, 2025 | — |
| 4 | Insider transaction | Sep 16, 2025 | Sep 15, 2025 |
| UPLOAD | Letter from the SEC | Sep 16, 2025 | — |
| 4 | Insider transaction | Aug 15, 2025 | Aug 15, 2025 |
| CORRESP | Letter to the SEC | Aug 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | Aug 11, 2025 | — |
| 10-Q | Quarterly report | Aug 6, 2025 | Jun 30, 2025 |
| 8-K |
Current report
Material agreement, Agreement ended, Results of operations, New debt
|
Aug 6, 2025 | Aug 5, 2025 |
| 4 | Insider transaction | Aug 1, 2025 | Jul 30, 2025 |
| UPLOAD | Letter from the SEC | Jul 30, 2025 | — |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Jul 29, 2025 | — |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| 4 | Insider transaction | Jul 28, 2025 | Jul 24, 2025 |
| CORRESP | Letter to the SEC | Jul 23, 2025 | — |
| 4 | Insider transaction | Jul 16, 2025 | Jul 15, 2025 |
| UPLOAD | Letter from the SEC | Jul 16, 2025 | — |
| 144 | Notice of proposed sale | Jul 15, 2025 | — |
| 4 | Insider transaction | Jun 30, 2025 | Jun 26, 2025 |
| 4 | Insider transaction | Jun 18, 2025 | Jun 16, 2025 |
| 4 | Insider transaction | Jun 16, 2025 | Jun 12, 2025 |
| 144 | Notice of proposed sale | Jun 12, 2025 | — |
| 4 | Insider transaction | Jun 11, 2025 | Jun 9, 2025 |
| 4 | Insider transaction | Jun 10, 2025 | Jun 9, 2025 |
| 144 | Notice of proposed sale | Jun 9, 2025 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2025 | Jun 4, 2025 |
| 144 | Notice of proposed sale | Jun 4, 2025 | — |
| 4 | Insider transaction | May 23, 2025 | May 21, 2025 |
| 144 | Notice of proposed sale | May 21, 2025 | — |
| 4 | Insider transaction | May 16, 2025 | May 15, 2025 |
| SCHEDULE 13G | Ownership over 5% (passive) | May 13, 2025 | — |
| SCHEDULE 13G | Ownership over 5% (passive) | May 9, 2025 | — |
| 10-Q | Quarterly report | May 7, 2025 | Mar 31, 2025 |
| 8-K |
Current report
Results of operations, Other events
|
May 7, 2025 | May 5, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Apr 30, 2025 | — |
| 8-K |
Current report
Other events
|
Apr 28, 2025 | Apr 28, 2025 |
| 4 | Insider transaction | Apr 16, 2025 | Apr 15, 2025 |
| ARS | Annual report to shareholders | Apr 15, 2025 | Dec 31, 2024 |
| DEFA14A | Additional proxy material | Apr 15, 2025 | — |
| DEF 14A | Proxy statement | Apr 15, 2025 | Jun 4, 2025 |
| 4 | Insider transaction | Apr 2, 2025 | Apr 1, 2025 |
| 4 | Insider transaction | Mar 21, 2025 | Mar 19, 2025 |
| 144 | Notice of proposed sale | Mar 19, 2025 | — |
| 10-K | Annual report | Mar 18, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| 4 | Insider transaction | Mar 10, 2025 | Mar 6, 2025 |
| NT 10-K | Filing | Mar 3, 2025 | Dec 31, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2025 | Mar 3, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 25, 2025 |
| 4 | Insider transaction | Feb 27, 2025 | Feb 26, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 4 | Insider transaction | Feb 21, 2025 | Feb 19, 2025 |
| 8-K |
Current report
Officer or director change
|
Feb 21, 2025 | Feb 19, 2025 |
| SCHEDULE 13G/A | Amended ownership over 5% (passive) | Feb 7, 2025 | — |
| 4 | Insider transaction | Feb 3, 2025 | Jan 30, 2025 |
| 8-K |
Current report
Regulation FD disclosure
|
Jan 13, 2025 | Jan 13, 2025 |
| 8-K |
Current report
Results of operations
|
Jan 13, 2025 | Jan 13, 2025 |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 3, 2025 | Dec 31, 2024 |
| 4 | Insider transaction | Jan 2, 2025 | Dec 30, 2024 |
| 3 | Initial insider ownership | Jan 2, 2025 | Dec 30, 2024 |
| 8-K |
Current report
Officer or director change
|
Jan 2, 2025 | Dec 30, 2024 |
| 8-K |
Current report
Other events
|
Dec 20, 2024 | Dec 20, 2024 |
| 4 | Insider transaction | Dec 2, 2024 | Nov 27, 2024 |
| 4 | Insider transaction | Nov 22, 2024 | Nov 22, 2024 |
| 4 | Insider transaction | Nov 22, 2024 | Nov 22, 2024 |
| 144 | Notice of proposed sale | Nov 22, 2024 | — |
| 144 | Notice of proposed sale | Nov 22, 2024 | — |
| 8-K |
Current report
Officer or director change
|
Nov 21, 2024 | Nov 19, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Nov 12, 2024 | — |
| SC 13G | Ownership over 5% (passive) | Nov 8, 2024 | — |
| 10-Q | Quarterly report | Nov 7, 2024 | Sep 30, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 7, 2024 | Nov 7, 2024 |
| SC 13G | Ownership over 5% (passive) | Nov 4, 2024 | — |
| 8-K |
Current report
Auditor change
|
Oct 31, 2024 | Oct 31, 2024 |
| SC 13G | Ownership over 5% (passive) | Oct 17, 2024 | — |
| 8-K |
Current report
Regulation FD disclosure
|
Oct 10, 2024 | Oct 9, 2024 |
| 8-K |
Current report
Auditor change
|
Oct 9, 2024 | Oct 3, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Oct 7, 2024 | — |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| 4 | Insider transaction | Oct 2, 2024 | Sep 30, 2024 |
| SC 13G | Ownership over 5% (passive) | Sep 23, 2024 | — |
| 4 | Insider transaction | Sep 11, 2024 | Sep 9, 2024 |
| 144 | Notice of proposed sale | Sep 9, 2024 | — |
| 4 | Insider transaction | Aug 30, 2024 | Aug 30, 2024 |
| 4 | Insider transaction | Aug 30, 2024 | Aug 29, 2024 |
| 144 | Notice of proposed sale | Aug 30, 2024 | — |
| 144 | Notice of proposed sale | Aug 29, 2024 | — |
| 4 | Insider transaction | Aug 27, 2024 | Aug 26, 2024 |
| 4 | Insider transaction | Aug 27, 2024 | Aug 23, 2024 |
| 144 | Notice of proposed sale | Aug 26, 2024 | — |
| 8-K |
Current report
Other events
|
Aug 14, 2024 | Aug 14, 2024 |
| 10-Q | Quarterly report | Aug 8, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 8, 2024 | Aug 8, 2024 |
| 4 | Insider transaction | Jul 26, 2024 | Jul 24, 2024 |
| 4 | Insider transaction | Jul 26, 2024 | Jul 24, 2024 |
| 3 | Initial insider ownership | Jul 26, 2024 | Jul 24, 2024 |
| 8-K |
Current report
Officer or director change
|
Jul 26, 2024 | Jul 24, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 30, 2024 |
| 4 | Insider transaction | Jul 2, 2024 | Jun 30, 2024 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Jun 28, 2024 | Jun 27, 2024 |
| 4 | Insider transaction | Jun 14, 2024 | Jun 14, 2024 |
| 144 | Notice of proposed sale | Jun 14, 2024 | — |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2024 | Jun 4, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
May 17, 2024 | May 17, 2024 |
| 10-Q | Quarterly report | May 9, 2024 | Mar 31, 2024 |
| 8-K |
Current report
Results of operations
|
May 9, 2024 | May 9, 2024 |
| ARS | Annual report to shareholders | Apr 15, 2024 | Dec 31, 2023 |
| DEFA14A | Additional proxy material | Apr 15, 2024 | — |
| DEF 14A | Proxy statement | Apr 15, 2024 | Jun 4, 2024 |
| 4 | Insider transaction | Apr 2, 2024 | Mar 31, 2024 |
| 4 | Insider transaction | Apr 2, 2024 | Mar 31, 2024 |
| 3 | Initial insider ownership | Apr 2, 2024 | Apr 1, 2024 |
| 8-K |
Current report
Officer or director change
|
Apr 2, 2024 | Apr 1, 2024 |
| 4 | Insider transaction | Mar 19, 2024 | Mar 18, 2024 |
| 4 | Insider transaction | Mar 15, 2024 | Mar 13, 2024 |
| 144 | Notice of proposed sale | Mar 13, 2024 | — |
| 8-K |
Current report
Other events
|
Mar 11, 2024 | Mar 11, 2024 |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 11, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 11, 2024 | — |
| SC 13G/A | Amended ownership over 5% (passive) | Mar 11, 2024 | — |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 4 | Insider transaction | Mar 8, 2024 | Mar 6, 2024 |
| 8-K |
Current report
Regulation FD disclosure
|
Mar 5, 2024 | Mar 4, 2024 |
| 4 | Insider transaction | Mar 4, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Mar 4, 2024 | Feb 29, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 4 | Insider transaction | Feb 28, 2024 | Feb 26, 2024 |
| 10-K | Annual report | Feb 28, 2024 | Dec 31, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Feb 28, 2024 | Feb 26, 2024 |
| 8-K |
Current report
Results of operations
|
Feb 28, 2024 | Feb 28, 2024 |
Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Biological Products, (No Diagnostic Substances) (SIC 2836)
- Listed as
- ADMA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Ramsey, NJ
- SEC filer status
- Large accelerated filer
- SEC CIK
- 1368514
- Former names
- R&R ACQUISITION VI, INC (until Feb 21, 2012)
Other Biological Products, (No Diagnostic Substances) companies
- Amgen Inc AMGN
- Gilead Sciences, Inc. GILD
- Moderna, Inc. MRNA
- Argenx SE ARGX
- Revolution Medicines, Inc. RVMD
- Biogen Inc. BIIB
- BioNTech SE BNTX
- Exelixis, Inc. EXEL
All 182 Biological Products, (No Diagnostic Substances) companies
Source: SEC EDGAR filings. This is company-reported data, not investment advice.